HighTower Advisors, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q4 2021$48,000
-9.4%
15,0000.0%0.00%
Q3 2021$53,000
+10.4%
15,000
-0.8%
0.00%
Q2 2021$48,000
-5.9%
15,115
+0.8%
0.00%
Q1 2021$51,000
+104.0%
15,000
+50.0%
0.00%
Q4 2020$25,000
+19.0%
10,0000.0%0.00%
Q3 2020$21,00010,0000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders